Loading...
Esjay Pharma Private Limited — Lorazepam Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Lorazepam · $200.0K export value · DGFT Verified
Esjay Pharma Private Limited is the #4 Indian exporter of Lorazepam with $200.0K in export value and 4 verified shipments. Esjay Pharma Private Limited holds a 8.0% market share in Lorazepam exports across 1 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.1M | 23 | 50.5% |
| UNITED KINGDOM | $336.0K | 28 | 14.8% |
| FINLAND | $282.4K | 18 | 12.4% |
| SWITZERLAND | $132.8K | 4 | 5.8% |
| SRI LANKA | $100.0K | 2 | 4.4% |
| MYANMAR | $82.0K | 4 | 3.6% |
| GERMANY | $79.9K | 3 | 3.5% |
| NICARAGUA | $42.3K | 11 | 1.9% |
| SOMALIA | $20.2K | 4 | 0.9% |
| KENYA | $15.5K | 3 | 0.7% |
India exports Lorazepam to 21 countries. The top destination is UNITED STATES (50.5%), followed by UNITED KINGDOM and FINLAND.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| XXROBXXDO XXARMXXUSAXX INXX | UNITED STATES | $454.5K | 10 |
| AUROBINDO PHARMA USA INC | UNITED STATES | $400.0K | 8 |
| ORION CORPORATION | FINLAND | $260.6K | 14 |
| GENESIS PHARMACEUTICALS LIMITED | UNITED KINGDOM | $176.4K | 10 |
| SPIRIG HEALTHCARE AG | SWITZERLAND | $132.8K | 4 |
India exported $2.2M worth of Lorazepam through 125 shipments from 24 suppliers to 21 countries, serving 46 buyers globally. Esjay Pharma Private Limited contributes $200.0K to this total, accounting for 8.0% of India's Lorazepam exports.
Esjay Pharma Private Limited's average Lorazepam shipment value is $50.0K per consignment, based on 4 shipments totaling $200.0K.
Esjay Pharma Private Limited ranks #4 among 24 Indian Lorazepam exporters with a 8.0% market share. The top 3 exporters are APL HEALTHCARE LIMITED ($947.1K), CENTAUR PHARMACEUTICALS PRIVATE LIMITED ($471.7K), ESJAY PHARMA PRIVATE LIMITED ($200.0K). Esjay Pharma Private Limited processed 4 shipments to 1 destination countries.
What Esjay Pharma Private Limited must comply with to export Lorazepam to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | APL HEALTHCARE LIMITED | $947.1K | 19 | 1 | $49.8K |
| 2 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED | $471.7K | 30 | 4 | $15.7K |
| 4 | ESJAY PHARMA PRIVATE LIMITED ★ | $200.0K | 4 | 1 | $50.0K |
| 5 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $156.3K | 19 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 22 | 17.6% |
| NHAVA SHEVA SEA (INNSA1) | 16 | 12.8% |
| JNPT/ NHAVA SHEVA SEA | 13 | 10.4% |
| CHENNAI AIR CARGO ACC (INMAA4) | 11 | 8.8% |
| APIIC LIMITED -NAIDUPETA SEZ | 11 | 8.8% |
| JNPT | 7 | 5.6% |
| Naidupeta Apiic | 5 | 4.0% |
| DELHI AIR CARGO ACC (INDEL4) | 4 | 3.2% |
Latest developments and market context
Detailed market intelligence for Lorazepam — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Esjay Pharma Private Limited's Lorazepam exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| GENESIS PHARMACEUTICALS LIMITED. |
| UNITED KINGDOM |
| $113.7K |
| 10 |
| ANIP ACQUISTION COMPANY | UNITED STATES | $100.0K | 2 |
| ESPARMA PHARMA SERVICES GMBH | GERMANY | $79.9K | 3 |
| THE PURCHASE MANAGER | UNITED STATES | $66.7K | 2 |
| ORION CORPORATION, | FINLAND | $21.8K | 2 |
India's Lorazepam is purchased by 46 buyers worldwide. The top buyer is XXROBXXDO XXARMXXUSAXX INXX (UNITED STATES), followed by AUROBINDO PHARMA USA INC and ORION CORPORATION.
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 2 |
| $8.2K |
| 3 | VENOR PHARMA LIMITED | $150.0K | 3 | 3 | $50.0K |
Esjay Pharma Private Limited ranks #4 among 24 Indian Lorazepam exporters. Average shipment value of $50.0K compared to the market average of $91.7K. The closest competitors by value are APL HEALTHCARE LIMITED and CENTAUR PHARMACEUTICALS PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 21+ countries, 46+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Esjay Pharma Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lorazepam. For current shipment-level data, contact TransData Nexus.